Cited by 360Diet, Metabolism, and DiseaseAdipokines, Inflammation, and Metabolic DiseasesGut microbiota and health

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.

Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet

Gao, Xiang, Liu, Xiaofang, Xu, Jie, Xue, Changhu, Xue, Yong, Wang, Yuming·2014·Journal of Bioscience and Bioengineering

DOI 10.1016/j.jbiosc.2014.03.001

Open this paper in CoChat — free account

Abstract

Trimethylamine N-oxide (TMAO) is an oxidation product of trimethylamine (TMA) and is present in many aquatic foods. Here, we investigated the effects of TMAO on glucose tolerance in high fat diet (HFD)-fed mice. Male C57BL/6 mice were randomly assigned to the control, high fat (HF), and TMAO groups. The HF group was fed a diet containing 25% fat, and the TMAO group was fed the HFD plus 0.2% TMAO for 4 weeks. After 3 weeks of feeding, oral glucose tolerance tests were performed. Dietary TMAO increased fasting insulin levels and homeostasis model assessment-estimated insulin resistance (HOMA-IR) and exacerbated the impaired glucose tolerance in HFD-fed mice. These effects were associated with the expression of genes related to the insulin signal pathway, glycogen synthesis, gluconeogenesis and glucose transport in liver. mRNA levels of the pro-inflammatory cytokine MCP-1 increased significantly and of the anti-inflammatory cytokine IL-10 greatly decreased in adipose tissue. Our results suggest that dietary TMAO exacerbates impaired glucose tolerance, obstructs the hepatic insulin signaling pathway, and causes adipose tissue inflammation in mice fed a high fat diet.

Integrity signals

Registry

Crossref · 10.1016/j.jbiosc.2014.03.001

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Phosphorus Assay in Column Chromatography
Bartlett, G. R. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70226-3 · Cited by 12,802
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,345
The Continuing Epidemics of Obesity and Diabetes in the United States
Mokdad, A. H. (2001) · JAMA · doi:10.1001/jama.286.10.1195 · Cited by 2,730

Flagged first, then by citations

Show all 44 references

1 of the 44 references couldn’t be matched to a known paper.

Sorted by citations

Items 301–360 of 360

Urine and Serum Metabolomic Profiles Differ by Disease Activity in Pregnant Women With Inflammatory Bowel Diseases
Wu, R., Tandon, P., Oh, J. S., Ambrosio, L., Hotte, N., Shah-Gandhi, B., Madsen, K. L., Dieleman, L. A., Elahi, S., Kroeker, K. I., et al. (2022) · Gastro Hep Advances · doi:10.1016/j.gastha.2022.07.008 · Cited by 4
Association of serum N,N,N-trimethyl-5-aminovaleric acid, trimethylamine N-oxide, and trimethyllysine levels with gestational diabetes mellitus
Cai, P., Zheng, Y., Chen, L., Fang, Q., Lei, Y., & She, Z. (2025) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2025.2467999 · Cited by 4
Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial
Yang, X., Zhang, X., Sun, C., Zhao, C., Kong, X., Zhao, M., Ji, L., & Li, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1575087 · Cited by 4
Prognostic value of gut microbiota-derived trimethylamine N-oxide in patients with ischemic stroke: A meta-analysis
Tang, L., Zhang, L., Zeng, Y., Li, S., & Li, Y. (2023) · Neurology Asia · doi:10.54029/2023jth · Cited by 5
Unravelling the gut-liver axis: The role of gut microbiota-mitochondria interactions in the pathogenesis and management of metabolic-associated fatty liver disease (MAFLD)
Zhang, B., Luo, X., Lei, S., Gao, W., Chen, Z., Zhu, Q., Huang, L., & Long, Q. (2025) · Journal of Holistic Integrative Pharmacy · doi:10.1016/j.jhip.2025.02.001 · Cited by 3
Metabolomic Profiling of Hepatitis B-Associated Liver Disease Progression: Chronic Hepatitis B, Cirrhosis, and Hepatocellular Carcinoma
Oh, J., Baritugo, K., Kim, J., Park, G. K., Han, K. J., Lee, S., & Sung, G. (2025) · Metabolites · doi:10.3390/metabo15080504 · Cited by 3
Bmal1 deficiency in neutrophils alleviates symptoms induced by high-fat diet
Leinweber, B., Pilorz, V., Olejniczak, I., Skrum, L., Begemann, K., Heyde, I., Stenger, S., Sadik, C. D., & Oster, H. (2025) · iScience · doi:10.1016/j.isci.2025.112038 · Cited by 3
Difference in oral microbiota composition between patients with stage 5 chronic kidney disease on hemodialysis and healthy controls.
Gan, Y., Ruan, D., Zeng, Q., Zhu, Y., Hu, Y., Wu, R., Lin, X.-F., Wu, J., Meng, X., Luo, J.-W., et al. (2023) · PubMed Central · Cited by 3
Gut Microbiota and Type 2 Diabetes Mellitus
Longo, S., Menghini, R., & Federici, M. (2024) · Endocrinology · doi:10.1007/978-3-031-35064-1_8 · Cited by 3
Therapeutic blockade of CCL17 in obesity-exacerbated osteoarthritic pain and disease
Lee, M.-C., Lupancu, T. J., Keenan, S. N., Bing, G., Achuthan, A. A., Biondo, M., Lieu, K. G., Watt, M. J., Maraskovsky, E., Kingwell, B. A., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0317399 · Cited by 3
MAFLD under the lens: the role of gut microbiota
Sousa, P., & Machado, M. V. (2022) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2022.15 · Cited by 3
Nutraceuticals as Therapeutic Agents for Prevention and Treatment of Diseases
Sachdeva, H., Khaturia, S., & Chahar, M. (2022) · Springer eBooks · doi:10.1007/978-981-16-8990-1_4 · Cited by 5
Maresin-1 and S-Equol as Emerging Metabolic Biomarkers in Gestational Diabetes-Associated Inflammation
Yavuzkır, Ş., Cinar, D. K., Çınar, A., Bildirici, F., & Aydın, S. (2025) · Diagnostics · doi:10.3390/diagnostics15192439 · Cited by 2
The Effect of Egg Yolk Oil in Repairing Tight Junction Claudin-1 in Periodontitis in a Wistar Rat
Mustafa, H. H. N. (2022) · Pakistan Veterinary Journal · doi:10.29261/pakvetj/2022.069 · Cited by 2
Role of the Microbiome in Cardiovascular Disease
Chaikijurajai, T., Wilcox, J. D., & Tang, W. H. W. (2021) · Contemporary cardiology · doi:10.1007/978-3-030-78177-4_15 · Cited by 2
Lipid status, microbiota and bile acids: clinical and pathogenetic relationships
Успенский, Ю. П., Фоминых, Ю. А., & Наджафова, К. Н. (2022) · University therapeutic journal · doi:10.56871/7123.2022.64.86.001 · Cited by 2
Role of Renin Angiotensin System in the Pathophysiology of Coronary Heart Disease: Advancements in Diagnosis, Therapy and Preventive Strategies
Mehta, J. K., Banerjee, M., Shah, P. H., Kaur, G., & Buttar, H. S. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-14952-8_14 · Cited by 2
Microbiome-Targeted Therapies: Enhancing Resilience in Metabolic Disorders
Janiad, S., & Rehman, K. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_13 · Cited by 1
Relationship between dietary inflammatory index and predominant intestinal bacterial phylum in healthy pregnant women compared to gestational diabetes
Nasiri, M., Mousavi, S. N., Rad, Z. A., & Heidarzadeh, S. (2025) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-025-01491-0 · Cited by 1
Evaluation of prothymosin alpha, trimethylamine-N-oxide, and ischemia-modified albumin in type 2 diabetes mellitus patients with dysregulated lipid profile
Gharab, K. M. K., Bik, M. A., Atta, S. E., Jawad, G. S., Almaghrebi, E., Salman, I. N., & Ünlü, A. (2025) · Qatar medical journal · doi:10.5339/qmj.2025.39 · Cited by 1
Tryptophan and polyamine metabolism dysregulation serves as an early marker of high-fat diet-induced glucose intolerance
Gao, J., Zhang, L., Zhan, S., Peng, Z., Du, J., Zhang, Z. X., Xu, L., Huang, S., Wang, X., & Guo, X. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.100980 · Cited by 1
Gut microbiota-derived metabolite trimethylamine N-oxide in major adverse cardiovascular events: Mechanisms, risk assessment, and therapeutic strategies
Alvarado, S. J., Enciso, M. F. F., Amedei, A., & Aguirre‐García, M. M. (2026) · World Journal of Cardiology · doi:10.4330/wjc.v18.i3.116780 · Cited by 1
Gut Microbiota-Derived TMAO Drives MC3T3-E1 Senescence and Osteogenic Dysfunction via cGAS–STING–NF-κB Signaling: Implications for Age-Related Bone Loss
Li, L., Xinsai, L., Jin, M., Zhang, Y., Bai, J., An, J., Yang, Y., Li, S., & An, J. (2026) · Calcified Tissue International · doi:10.1007/s00223-026-01567-x · Cited by 2
Chronic Liver Disease and Promising Therapeutic Strategy: A Concise Review
Yu, H., Wang, Z., & Zhao, G. (2024) · Pharmacognosy Magazine · doi:10.1177/09731296241228361 · Cited by 1
Decoding the Link: Exploring FMO3 Gene Variations as a Key to Understanding Type Two Diabetes Through Bioinformatics and Case–Control Analyses
Shokati, S., Sargazi, S., Majidpour, M., Mirinejad, S., Ghale-Noie, Z. N., Shahraki, M., Sargazi, S., & Piri, M. (2025) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-024-01295-9 · Cited by 1
Identificación de componentes de la microbiota intestinal potencialmente beneficiosos frente a la obesidad
Villanueva, E. M. G. D. P. (2018) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/114770
Role of Hepatic PEMT and Dietary Choline in the Development of Atherosclerosis
Zia, Y. (2017) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3736mj2x
The Role of Gut Microbiome-Targeted Therapy in Nonalcoholic Fatty Liver Disease
Xie, C., & Halegoua-DeMarzio, D. L. (2020) · Current Hepatology Reports · doi:10.1007/s11901-020-00547-5
HUMAN GUT MICROBIOTA AND ITS EFFECTS ON HUMAN HEALTH IN NORMAL AND PATHOLOGICAL CONDITIONS
Munteanu, A. M., Cursaru, R., Guja, L., Carniciu, S., Borcan, A. M., & Popescu‐Spineni, D. (2017) · Romanian Medical Journal · doi:10.37897/rmj.2017.3.2
Dietary choline activates brown fat to reduce adiposity and cholesterol in APOE*3-Leiden.CETP micePreprint
Liu, C., Song, Z., Zhuang, L., Boon, M. R., Schönke, M., Rensen, P. C. N., & Wang, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-2049041/v1
Self-citation
Trimethylamine N-oxide impairs β-cell function and glucose tolerancePreprint
Kong, L., Zhao, Q., Jiang, X., Jiang, Q., Li, S., peng, X., Wang, S., Chen, Y., Hou, S., Liu, X., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2465481/v1
Self-citation
Progress on the Role of “Gutbacteria-Gut-Liver Axis” in Non-Alcoholic Fatty Liver Disease
陈, 孟. (2023) · Medical Diagnosis · doi:10.12677/md.2023.132038
THE ROLE OF THE INTESTINAL MICROBIOTA METABOLITE TMAO IN THE PATHOGENESIS OF VARIOUS DISEASES
Samoilova-Bedych, N., Laryushina, Е. М., Marchenko, A., & Сейсенбекова, А. К. (2024) · Farmaciâ Kazahstana · doi:10.53511/pharmkaz.2024.25.65.015
Involvement of Osmolytes in the Pathophysiology of Various Human Diseases
Srinivasan, V., & Khan, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-6001-5_6
Childhood Obesity: Systemic Complications, Early Atherosclerosis and the Value of Carotid Intima-Media Thickness
Mihuţa, M. S., Paul, C., Borlea, A., Roi, C. M., Pescari, D., & Stoian, D. L. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009275
ЭНДОТЕЛИАЛЬНАЯ ДИСФУНКЦИЯ - РАННИЙ МАРКЕР ПОРАЖЕНИЯ СЕРДЕЧНО-СОСУДИСТОЙ СИСТЕМЫ У ДЕТЕЙ С ОЖИРЕНИЕМ
Фармановна, И. Э., & Маратовна, Г. Л. (2025) · Международный журнал научной педиатрии · doi:10.56121/2181-2926-2025-4-3-1021-1025
Serum trimethylamine N-oxide and long-term mortality risk in rural northern China: a family-based cohort study
Wang, M., Peng, H., Yang, R., Yu, H., Hou, T., Wu, Y., Qin, X., Li, J., Chen, D., Hu, Y., et al. (2025) · British Journal Of Nutrition · doi:10.1017/s0007114525104224
Additional file 1 of Serum trimethylamine-N-oxide is associated with incident type 2 diabetes in middle-aged and older adults: a prospective cohort study
Li, S.-Y., Chen, S., Lu, X.-T., Fang, A.-P., Chen, Y.-M., Huang, R.-Z., Lin, X.-L., Huang, Z.-H., Ma, J.-F., Huang, B.-X., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20517119
Interplay between intestinal permeability and metabolic dysfunction-associated steatotic liver disease: Could there be a role for extra virgin olive oil consumption?
Giannitrapani, L., Ferraro, M., Seidita, A., Licata, A., & Soresi, M. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i12.110076
Probiotics for managing non-alcoholic fatty liver disease: efficacy and mechanistic insights
Ghosh, S., Ghosh, A. J., Adhikari, M. D., Tiwary, B. K., & Saha, T. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01861-3
Association of dietary choline and betaine intake with diabetes risk: a prospective cohort study from the China Health and Nutrition Survey
Wu, S., Chen, P., Yi, S., Tan, P., Lu, J., Wang, W., Lu, W., & Fang, A. (2026) · Food & Function · doi:10.1039/d5fo02252e
Circulating microbiome and its clinical implications in diabetes mellitus: Mechanistic insights and therapeutic perspectives
Vasudevan, D. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i3.113843
The saturation degree of dietary fatty acids alters the phenotypes of lipoprotein subclasses and plasma metabolome in piglets
Li, Y., Wang, Y., Ma, R., Li, Z., Feng, Z., Kong, X., Zhou, Q., Guo, X., Yin, Y., Wu, Y., et al. (2026) · Food Chemistry · doi:10.1016/j.foodchem.2026.149072
Self-citation
Rôle de 3 toxines urémiques : p-Cresyl Sulfate, Zinc α2-Glycoproteine et Trimethylamine-N-Oxide dans les complications métaboliques secondaires de la maladie rénale chronique
Pelletier, C. (2018) · theses.fr (ABES) · doi:10.70675/125b4f8bzf779z4b21zb730z19d0af849144
Le microbiote intestinal comme cible thérapeutique dans la maladie alcoolique du foie : implication des acides biliaires et de la pectine
Ciocan, D. M. (2018) · theses.fr (ABES) · doi:10.70675/f76b0335zd8baz4b14za916zd8a1cbd3325c
Predicting poor prognosis risk after endovascular thrombectomy for acute ischemic stroke: combination of TMAO and white matter lesions
Zhou, C., Yuan, Q.-Y., Wang, Y.-K., Zhong, C., Liu, Y. Q., Gao, F.-F., Liu, R.-R., Li, W., Qin, R.-Y., Zhu, S.-G., et al. (2026) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2026.2643859
Self-citation
Classification of intestinal inflammation driven by gut microbiota metabolites: a new paradigm for precision treatment of cardiovascular diseases
Zhao, D., Cui, Y., & Hua, Z. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1783688
Metabolic and Endocrinological Aspects of Gut Microbiota
Longo, S., Antonetti, L., Casagrande, V., Antonucci, A., Mollace, R., Menghini, R., & Federici, M. (2026) · Endocrinology · doi:10.1007/978-3-030-71067-5_13-1
Gut microbiota-generated trimethylamine N -oxide from dietary choline and glucose homeostasis in humans
Laskaridou, E., Steele, C. N., Reid, G. R., Rinehart, J. T., Marinik, E. L., Howard, K. R., Davy, B. M., Sweet, M. G., Neilson, A. P., & Davy, K. P. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00160.2026
Elevated plasma TMAO levels associated with all-cause mortality in CAD patients in South China
Zhang, H., Peng, Y., Lu, X.-Y., Li, Y. Y., Li, W., Hu, Y., Li, W., & Chen, B.-L. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06214-9
Serum Metabolomics Reveals Impaired Fatty Acid Oxidation and Elevated One-Carbon Demand in Cats Fed a Low-Protein Diet Compared with a Low-Fat or Low-Carbohydrate Diet
Godfrey, H., Yang, J., He, E., Kelly, J., Kostiuk, D., Blades, J. S., Shoveller, A. K. K., & Verbrugghe, A. (2026) · Journal of Nutrition · doi:10.1016/j.tjnut.2026.101733
Source- and Solubility-specific Choline, Gut Microbiota, and Dyslipidemia Risk: Trimethylamine N-oxide-associated and Non–trimethylamine N-oxide-Associated Patterns in a Prospective Cohort Study
Zhang, X., Jia, X., Zhang, J., Guan, F., Wei, Y., Du, S., Du, W., Huang, F., Ouyang, Y., Li, L., et al. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101440
Metabolic Syndrome: From Mechanisms to Therapeutic Interventions
Yan, M., & Xiang, Q. (2026) · MedComm · doi:10.1002/mco2.70934
Gut-liver axis and intestinal microbiota: Key targets of herbal medicines in treatment of MASLD/MASH
Mao, Y., Wei, C., Zhang, Y., Zheng, Y., Ji, R., Ge, L. I. N., He, X., He, Y., Yang, J., & Ma, J. (2026) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2026.08.017
Delay of diabetic cataract progression by a chemical chaperone trimethylamine N-oxide through alleviating unfolded-protein-induced ER stress
Shen, J., Jiang, J., 刘高勤, Liu, W., Ren, H., & Lu, P. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111240
Advances and perspectives in genetically encoded biosensors for biomarker detection and theranostic circuits
Xu, J., Qi, Q., & Wang, Q. (2026) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2026.09.006
Self-citation
Nanoparticles and the gut-microbiome: a dual strategy for oral brain delivery
Negahdari, R., Pouyanfar, N., Masoudifar, R., Aftabi, P., Fendereski, F., Anvari, Z., Masoumi, N., Faizi, M., & Ghorbani‐Bidkorbeh, F. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127477
A review on the beneficial and detrimental roles of gut microbiota-derived trimethylamine-N-oxide (TMAO)
Rajabi, E., Seyedi, Z. P., Ghamari, M., Mohammadzadeh, R., Mansouri, M., Götz, F., & Bostanghadiri, N. (2026) · Infectious Medicine · doi:10.1016/j.imj.2026.100290
TMAO at the Crossroads of the Gut–Brain Axis: Emerging Mechanisms Linking Microbiota-Derived Metabolites to Neuroinflammation and Cognitive Dysfunction
Altahrawi, A. Y., Sofi, F., Kanjwal, Z., & Shah, Z. A. (2026) · Cells · doi:10.3390/cells15201845
Microbiota-derived toxicants targeting mitochondria
Bahitham, W., Almuaiqly, G., Abumelha, W., Ghazzawi, R., Ghazzawi, G., Alsahafi, R., Sanai, F. M., Sergi, C. M., & Rosado, A. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45078-5.00023-3

Authors: Gao, X., Liu, X., Xu, J., Xue, C., Xue, Y., & Wang, Y.
Affiliations: Ocean University of China (CN)
Corresponding author: Wang, Yuming
ORCID: Gao, Xiang
Liu, Xiaofang
Xu, Jie
Xue, Changhu
Xue, Yong
Wang, Yuming
Venue: Journal of Bioscience and Bioengineering
Publisher: Elsevier BV
Published: 2014-10
Volume: 118
Issue: 4
Pages: 476-481
ISSN: 1347-4421 (ISSN-L)
1389-1723
DOI: 10.1016/j.jbiosc.2014.03.001
OpenAlex: W1965021718
Cited by: 360
References: 44
Citations by year: 2026: 26 · 2025: 40 · 2024: 35 · 2023: 36 · 2022: 42 · 2021: 42 · 2020: 34 · 2019: 33 · 2018: 18 · 2017: 21 · 2016: 19 · 2015: 12 · 2014: 2
FWCI: 14.47
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Bioscience and Bioengineering (publishedVersion)
PubMed (publishedVersion)
Funders: the National Key Technology R&D Program (2012BAD33B07)
National Natural Science Foundation of China (31371757)
Program for Changjiang Scholars and Innovative Research Team in University (IRT1188)
Taishan Scholars Programme of Shandong Province
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords: trimethylamine N-oxide, impaired glucose tolerance, high-fat diet, insulin resistance, hepatic insulin signaling, hepatic gluconeogenesis, hepatic glycogen synthesis, adipose tissue inflammation, MCP-1, IL-10, fasting insulin
MeSH terms: Adipose Tissue, Animals, Blood Glucose, Dietary Fats, Fasting, Glucose Tolerance Test, Inflammation, Insulin, Insulin Resistance, Liver, Male, Methylamines, Mice, Inbred C57BL, Interleukin-10, Glucose Intolerance, Chemokine CCL2, Mice, Diet, High-Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks